The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AERIE PHARMACEUTICALS INC | COM | 00771V108 | 1,765 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 32,290 | 1,761,567 | SH | SOLE | 1,761,567 | 0 | 0 | ||
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 15,604 | 1,516,387 | SH | SOLE | 1,516,387 | 0 | 0 | ||
| ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 103,354 | 1,951,183 | SH | SOLE | 1,951,183 | 0 | 0 | ||
| COLUCID PHARMACEUTICALS INC | COM | 19716T101 | 27,203 | 3,056,563 | SH | SOLE | 3,056,563 | 0 | 0 | ||
| FLEXION THERAPEUTICS INC | COM | 33938J106 | 46,694 | 2,133,131 | SH | SOLE | 2,133,131 | 0 | 0 | ||
| GLAUKOS CORP | COM | 377322102 | 2,174 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS INC | COM | 40434H104 | 14,274 | 1,280,185 | SH | SOLE | 1,280,185 | 0 | 0 | ||
| INOGEN INC | COM | 45780L104 | 158,300 | 3,549,320 | SH | SOLE | 3,549,320 | 0 | 0 | ||
| INVUITY INC | COM | 46187J106 | 10,457 | 740,616 | SH | SOLE | 740,616 | 0 | 0 | ||
| NEVRO CORP | COM | 64157F103 | 82,007 | 1,525,704 | SH | SOLE | 1,525,704 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 255,640 | 4,910,487 | SH | SOLE | 4,910,487 | 0 | 0 | ||
| OTONOMY INC | COM | 68906L105 | 20,117 | 875,025 | SH | SOLE | 875,025 | 0 | 0 | ||
| TOBIRA THERAPEUTICS INC | COM | 88883P101 | 46,513 | 2,696,405 | SH | SOLE | 2,696,405 | 0 | 0 | ||
| TOKAI PHARMACEUTICALS INC | COM | 88907J107 | 16,469 | 1,238,252 | SH | SOLE | 1,238,252 | 0 | 0 | ||
| VANGUARD INDEX FDS | TOTAL STK MKT | 922908769 | 318,823 | 2,979,100 | SH | SOLE | 2,979,100 | 0 | 0 | ||
| VANGUARD INTL EQUITY INDEX F | FTSE EUROPE ETF | 922042874 | 113,412 | 2,101,000 | SH | SOLE | 2,101,000 | 0 | 0 | ||
| WRIGHT MEDICAL GROUP | CONTINGENT VALUE RIGHTS | 98235T115 | 123,949 | 4,720,065 | PRN | SOLE | 0 | 0 | 4,720,065 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,471 | 127,563 | SH | SOLE | 127,563 | 0 | 0 | ||